The Economics of an ECMO Program: What to Model Before You Expand

Extracorporeal membrane oxygenation has moved from a rescue therapy at a handful of centers toward a service line that many programs are now considering. The clinical momentum is real. The financial discipline around it often is not.

Why ECMO is financially unlike routine cardiac surgery

ECMO is among the most resource-intensive therapies a hospital can offer: specialized disposables, continuous specialized staffing, extended ICU stays, and a high day-rate cost that accrues for as long as a patient is supported. A single prolonged run can dominate a month's service-line variance. That volatility is exactly why it must be modeled rather than assumed.

The variables that decide the margin

The staffing question is the whole question

Whether ECMO is managed by perfusion, by specially trained ICU staff, or by a hybrid team is the decision that most determines both cost and sustainability. Each model carries a different fixed-cost profile and a different exposure to the specialty labor market. Choosing it by default — because that is who happened to cover the first cases — is how programs end up structurally unprofitable.

Build the pro forma first

A credible ECMO business case projects volume by indication, models staffing against realistic call burden, applies honest payer assumptions, and stress-tests the result against a few long, expensive runs. Programs that do this expand with their eyes open. Programs that skip it discover the economics after the equipment is bought.